Skip to main content

Table 1 Patient characteristics

From: The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation

Variable

Value or No. of patients(%)

Sex

 Male

48 (71.6%)

 Female

19 (28.4%)

Median age (years, range)

59 (34~ 80)

Current smoker

 Yes

43 (64.2%)

 No

24 (35.8%)

Tumor type

 Recurrences

54 (80.6%)

 Metastases

10 (14.9%)

 New primary tumors

3 (4.5%)

Pathologic type

 NSCLC

36 (53.7%)

 SCLC

31 (46.3%)

Prior thoracic surgery

 Yes

17 (25.4%)

 No

50 (74.6%)

ECOG status before Re-RT

 0–1

61 (91.0%)

 2

6 (9.0%)

Chemotherapy

 Yes

19 (28.4%)

 No

48 (71.6%)

Initial RT technique

 Conventional

65 (97.0%)

 SBRT

2 (3.0%)

Re-RT technique

 Conventional

60 (89.6%)

 SBRT

7 (10.4%)

Re-RT location

 Central

47 (70.1%)

 Peripheral

20 (29.9%)

Re-RT location

 In field

33 (49.3%)

 Outside

34 (50.7%)

Median time to Re-RT(months, range)

16 (2–96)

Median follow-up(months, range)

9(4–76)

  1. Abbreviations: NSCLC non-small cell lung cancer, SCLC small cell lung cancer, Re-RT reirradiation, SBRT stereotactic ablative radiation therapy